XENE XENON PHARMACEUTICALS INC Operational Disruptions 8-K Filing 2023 - Clinical Trial Results Xenon Pharmaceuticals announced topline results from a clinical trial evaluating XEN1101 in patients with major depressive disorder.Get access to all SEC 8-K filings of the XENON PHARMACEUTICALS INC